Yasmin, Yaz Lawsuits Continue to Mount, Despite DVT, Pulmonary Embolism Settlements
Nearly one year after Bayer began negotiating settlements for claims involving women who suffered a pulmonary embolism or deep vein thrombosis, the total number of Yaz lawsuits and Yasmin lawsuits is continuing to increase.
According to a quarterly statement issued last month for investors, the total number of unresolved claims rose by more than 2,400 cases during the third quarter of 2012, despite the indication that the drug maker has reached Yaz and Yasmin settlements in about 3,490 DVT and pulmonary embolism lawsuits over the past year.
Bayer continues to face an estimated 12,400 claims, and the number of new Yaz and Yasmin lawsuits filed is clearly outpacing the number of settlements reached.
Yasmin, Yaz Lawyers Continuing to Review New Lawsuits
Bayer faces lawsuits involving a variety of different injuries that were allegedly caused by side effects of Yaz and Yasmin. However, to date, the drug maker has maintained that it is only willing to negotiate settlements in lawsuits that involve venous clot injuries, such as a DVT (where a blood clot from Yaz develops in the deep veins of the legs or pelvis) or pulmonary embolism (where a clot breaks free and travels to the lung).
Find Out If You or a Loved One May Have a Yaz or Yasmin Lawsuit
In addition to DVT and pulmonary embolism lawsuits over Yaz and Yasmin, Bayer also faces claims involving other blood-clot related injuries (such as strokes and heart attacks) and a large number of complaints that allege women suffered gallbladder disease from Yaz or Yasmin.
Bayer is negotiating settlements for pulmonary embolisms and DVTs on a case-by-case basis after an individual review of medical records in each case.
Cases are being settled in small groups, given the time consuming process of reviewing and negotiating the files.
The first settlements were reached just about one year ago, weeks before the first cases were set to go to trial.
Since then, the progress of the Yaz and Yasmin litigation throughout the country has largely been put on hold, or stayed, to allow the drug maker to focus their efforts on resolving cases.
All of the lawsuits involve similar claims that Bayer failed to adequately warn about the potential risks associated with their drospirenone-based birth control pills, and women continue to suffer injuries as a result of the inadequate warnings provided with Yaz, Yasmin and the related medications Ocella, Gianvi and Beyaz.
The product liability lawyers at Saiontz & Kirk, P.A., are continuing to review new cases for women who have suffered a serious blood clot injury from Yaz or Yasmin, and it is not too late to submit claims for settlement negotiations on behalf of women who have sufferd a pulmonary embolism or deep vein thrombosis.
All lawsuits are reviewed by our Yaz and Yasmin lawyers under a contingency fee agreement, which means that there are no fees or expenses unless we are successful obtaining financial compensation in the case. To review a potential claim for yourself, a friend or family member, request a free consultation and claim evaluation.